Finance

Beta
Lists
MNOV:NASDAQ
Medicinova Inc
$1.30
-1.52%
(-0.020) 1D
Jun 22, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MNOV...
Open
$1.31
High
$1.32
Low
$1.29
Mkt. cap
63.99M
Avg. vol.
33.79K
Volume
29.88K
52-wk high
$1.96
52-wk low
$1.17
EPS
-$0.24
Beta
0.62
Shares outstanding
49.22M
No. of employees
6
Open
$1.31
High
$1.32
Low
$1.29
Mkt. cap
63.99M
Avg. vol.
33.79K
Volume
29.88K
52-wk high
$1.96
52-wk low
$1.17
EPS
-$0.24
Beta
0.62
Shares outstanding
49.22M
No. of employees
6
News stories
From sources across the web
About Medicinova Inc
CEOYuichi Iwaki
Employees6
FoundedSep 26, 2000
HeadquartersLa Jolla, California, United States
SectorBiotechnology
Websitemedicinova.com
Analyst Ratings
Based on 2 analysts giving stock ratings to MNOV in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for MNOV in the last 3 months.
Highest
Current $1.30
$10.00 (+669.23%)
Average
$8.00 (+515.38%)
Lowest
$6.00 (+361.54%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
$6.00
+361.5%
05/27/2026
Lander Egana Gorrono
H.C. Wainwright
Buy
Maintained
$10.00
+669.2%
05/27/2026
Unknown Analyst
H.C. Wainwright
Buy
Initiated
$10.00
+669.2%
03/16/2026
Elemer Piros
Lucid Capital
Buy
Initiated
$11.00
+746.2%
01/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
134.60K
123.32K
151.74K
186.98K
Cost of goods sold
116.35K
115.27K
146.98K
170.10K
Cost of revenue
116.35K
115.27K
146.98K
170.10K
Research and development expenses
2.19M
1.58M
1.54M
1.26M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.44M
1.81M
1.55M
1.59M
Operating expense
3.63M
3.39M
3.10M
2.85M
Total operating expenses
3.74M
3.50M
3.24M
3.02M
Operating income
-3.61M
-3.38M
-3.09M
-2.84M
Other non operating income
952.00
-10.22K
-5.76K
-3.42K
EBT including unusual items
-3.28M
-3.05M
-2.80M
-2.59M
EBT excluding unusual items
-3.28M
-3.05M
-2.80M
-2.59M
Income tax expense
-
-
5.99K
-
Effective tax rate
-
-
-0.21%
-
Other operating expenses
-
-
-
-
Net income
-3.28M
-3.05M
-2.80M
-2.59M
Net profit margin
-2,437.75%
-2,473.56%
-1,846.78%
-1,383.14%
Earnings per share
-0.07
-
-0.05
-0.05
Interest and investment income
324.96K
340.85K
301.88K
252.96K
Interest expense
-
-
-
-
Net interest expenses
324.96K
340.85K
301.88K
252.96K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.60M
-3.38M
-3.09M
-2.83M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer